CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Pulse Biosciences, Inc. - PLSE CFD

    9.13
    1.33%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Pulse Biosciences Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 9.01
    Open* 9.35
    1-Year Change* 402.69%
    Day's Range* 8.86 - 9.47
    52 wk Range 1.65-9.69
    Average Volume (10 days) 207.20K
    Average Volume (3 months) 3.94M
    Market Cap 363.49M
    P/E Ratio -100.00K
    Shares Outstanding 54.99M
    Revenue -9,000.00
    EPS -0.89
    Dividend (Yield %) N/A
    Beta 1.41
    Next Earnings Date Mar 28, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 1, 2023 9.13 -0.29 -3.08% 9.42 9.52 8.79
    Nov 30, 2023 9.01 -0.07 -0.77% 9.08 9.50 8.70
    Nov 29, 2023 9.18 0.56 6.50% 8.62 10.08 8.48
    Nov 28, 2023 8.69 -0.29 -3.23% 8.98 9.59 8.48
    Nov 27, 2023 8.81 1.83 26.22% 6.98 8.95 6.98
    Nov 24, 2023 7.01 0.53 8.18% 6.48 7.31 6.48
    Nov 22, 2023 6.67 0.34 5.37% 6.33 6.77 6.33
    Nov 21, 2023 6.59 0.11 1.70% 6.48 7.33 6.15
    Nov 20, 2023 6.24 0.15 2.46% 6.09 6.58 5.97
    Nov 17, 2023 6.09 -0.20 -3.18% 6.29 6.31 5.92
    Nov 16, 2023 6.20 0.12 1.97% 6.08 6.55 5.92
    Nov 15, 2023 6.30 0.50 8.62% 5.80 6.45 5.60
    Nov 14, 2023 5.78 0.13 2.30% 5.65 5.98 5.18
    Nov 13, 2023 5.36 0.03 0.56% 5.33 5.72 5.25
    Nov 10, 2023 5.13 0.58 12.75% 4.55 5.16 4.55
    Nov 9, 2023 4.60 -0.31 -6.31% 4.91 5.13 4.56
    Nov 8, 2023 5.06 -0.10 -1.94% 5.16 5.23 4.70
    Nov 7, 2023 5.27 0.09 1.74% 5.18 5.53 4.91
    Nov 6, 2023 5.15 0.41 8.65% 4.74 5.53 4.74
    Nov 3, 2023 4.90 0.62 14.49% 4.28 4.99 4.28

    Pulse Biosciences, Inc. Events

    Time (UTC) Country Event
    Thursday, March 28, 2024

    Time (UTC)

    20:00

    Country

    US

    Event

    Q4 2023 Pulse Biosciences Inc Earnings Release
    Q4 2023 Pulse Biosciences Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0.7 1.418 0 0 0
    Revenue 0.7 1.418 0 0 0
    Total Operating Expense 58.757 64.432 49.965 47.954 37.963
    Selling/General/Admin. Expenses, Total 25.974 33.824 22.856 22.327 20.045
    Research & Development 20.839 28.64 26.444 24.961 17.253
    Depreciation / Amortization 0.665 0.666 0.665
    Unusual Expense (Income)
    Operating Income -58.057 -63.014 -49.965 -47.954 -37.963
    Interest Income (Expense), Net Non-Operating -0.448 -0.646 0.114 0.983 0.446
    Net Income Before Taxes -58.505 -63.66 -49.851 -46.971 -37.545
    Net Income After Taxes -58.505 -63.66 -49.851 -46.971 -37.545
    Net Income Before Extra. Items -58.505 -63.66 -49.851 -46.971 -37.545
    Net Income -58.505 -63.66 -49.851 -46.971 -37.545
    Income Available to Common Excl. Extra. Items -58.505 -63.66 -49.851 -46.971 -37.545
    Income Available to Common Incl. Extra. Items -58.505 -63.66 -49.851 -46.971 -37.545
    Diluted Net Income -58.505 -63.66 -49.851 -46.971 -37.545
    Diluted Weighted Average Shares 33.935 27.964 23.248 20.746 17.078
    Diluted EPS Excluding Extraordinary Items -1.72403 -2.2765 -2.14431 -2.2641 -2.19844
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS -1.69751 -2.2765 -2.14431 -2.2641 -2.19844
    Other, Net 0 -0.028
    Cost of Revenue, Total 11.944 1.968
    Gross Profit -11.244 -0.55
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0 0 0.7 0 0.265
    Revenue 0 0 0.7 0 0.265
    Total Operating Expense 10.227 9.562 58.757 18.025 14.279
    Selling/General/Admin. Expenses, Total 3.53 3.733 25.974 5.108 7.477
    Research & Development 6.697 5.829 20.839 4.517 5.458
    Unusual Expense (Income)
    Operating Income -10.227 -9.562 -58.057 -18.025 -14.014
    Interest Income (Expense), Net Non-Operating 0.317 -0.239 -0.448 -0.014 0.018
    Net Income Before Taxes -9.91 -9.801 -58.505 -18.039 -13.996
    Net Income After Taxes -9.91 -9.801 -58.505 -18.039 -13.996
    Net Income Before Extra. Items -9.91 -9.801 -58.505 -18.039 -13.996
    Net Income -9.91 -9.801 -58.505 -18.039 -13.996
    Income Available to Common Excl. Extra. Items -9.91 -9.801 -58.505 -18.039 -13.996
    Income Available to Common Incl. Extra. Items -9.91 -9.801 -58.505 -18.039 -13.996
    Diluted Net Income -9.91 -9.801 -58.505 -18.039 -13.996
    Diluted Weighted Average Shares 44.512 37.39 33.935 37.158 31.492
    Diluted EPS Excluding Extraordinary Items -0.22264 -0.26213 -1.72403 -0.48547 -0.44443
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.22264 -0.25945 -1.69751 -0.48009 -0.44443
    Cost of Revenue, Total 0 0 11.944 8.4 1.344
    Gross Profit 0 0 -11.244 -8.4 -1.079
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 62.147 36.63 22.339 26.403 60.362
    Cash and Short Term Investments 61.139 28.614 20.475 25.398 59.583
    Cash & Equivalents 61.139 28.614 12.463 6.899 51.103
    Short Term Investments 8.012 18.499 8.48
    Prepaid Expenses 1.008 2.131 1.864 1.005 0.779
    Other Current Assets, Total
    Total Assets 77.877 54.249 41.293 41.915 70.64
    Property/Plant/Equipment, Total - Net 10.023 11.247 11.916 7.68 2.173
    Goodwill, Net 2.791 2.791 2.791 2.791 2.791
    Intangibles, Net 2.551 3.216 3.882 4.547 5.213
    Total Current Liabilities 5.981 8.519 7.585 4.459 3.108
    Accounts Payable 1.573 2.904 1.717 1.963 1.272
    Accrued Expenses 3.491 5.163 5.868 2.496 1.421
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 80.125 18.559 18.399 11.178 4.306
    Total Long Term Debt 65 0 0 0 0
    Total Equity -2.248 35.69 22.894 30.737 66.334
    Common Stock 0.037 0.029 0.025 0.021 0.021
    Additional Paid-In Capital 292.42 271.861 195.41 153.401 142.032
    Retained Earnings (Accumulated Deficit) -294.705 -236.2 -172.54 -122.689 -75.718
    Other Equity, Total 0 0 -0.001 0.004 -0.001
    Total Liabilities & Shareholders’ Equity 77.877 54.249 41.293 41.915 70.64
    Total Common Shares Outstanding 37.235 29.716 25.55 20.825 20.593
    Property/Plant/Equipment, Total - Gross 12.976 13.643 13.832 9.166 3.165
    Accumulated Depreciation, Total -2.953 -2.396 -1.916 -1.486 -0.992
    Other Long Term Assets, Total 0.365 0.365 0.365 0.494 0.101
    Other Current Liabilities, Total 0 0.016 0.415
    Other Liabilities, Total 9.144 10.04 10.814 6.719 1.198
    Total Receivables, Net 0 0.061
    Accounts Receivable - Trade, Net 0 0.061
    Total Inventory 0 5.824
    Current Port. of LT Debt/Capital Leases 0.917 0.436
    Long Term Debt 65
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 51.623 59.958 54.947 62.147 71.161
    Cash and Short Term Investments 50.386 58.747 54.098 61.139 69.162
    Cash & Equivalents 50.386 58.747 54.098 61.139 69.162
    Short Term Investments
    Total Inventory 0 0.75
    Prepaid Expenses 1.237 1.211 0.849 1.008 1.244
    Total Assets 65.945 74.757 70.221 77.877 87.57
    Property/Plant/Equipment, Total - Net 9.114 9.425 9.734 10.023 10.536
    Property/Plant/Equipment, Total - Gross 12.471 12.649 12.822 12.976 13.452
    Accumulated Depreciation, Total -3.357 -3.224 -3.088 -2.953 -2.916
    Goodwill, Net 2.791 2.791 2.791 2.791 2.791
    Intangibles, Net 2.052 2.218 2.384 2.551 2.717
    Other Long Term Assets, Total 0.365 0.365 0.365 0.365 0.365
    Total Current Liabilities 5.432 5.613 6.991 5.981 6.998
    Accounts Payable 1.412 1.794 2.16 1.573 2.022
    Accrued Expenses 4.02 3.819 4.026 3.491 4.84
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0 0.801 0.917 0.098
    Total Liabilities 13.8 14.257 80.889 80.125 81.381
    Total Long Term Debt 0 0 65 65 65
    Long Term Debt 0 0 65 65 65
    Other Liabilities, Total 8.368 8.644 8.898 9.144 9.383
    Total Equity 52.145 60.5 -10.668 -2.248 6.189
    Common Stock 0.055 0.055 0.037 0.037 0.037
    Additional Paid-In Capital 377.072 374.861 293.801 292.42 291.66
    Retained Earnings (Accumulated Deficit) -324.982 -314.416 -304.506 -294.705 -285.508
    Other Equity, Total 0 0 0
    Total Liabilities & Shareholders’ Equity 65.945 74.757 70.221 77.877 87.57
    Total Common Shares Outstanding 54.991 54.771 37.593 37.235 37.228
    Total Receivables, Net 0 0.005
    Accounts Receivable - Trade, Net 0 0.005
    Other Current Liabilities, Total 0.004 0 0.038
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -58.505 -63.66 -49.851 -46.971 -37.545
    Cash From Operating Activities -47.013 -54.097 -35.365 -34.185 -23.896
    Cash From Operating Activities 0.69 0.48 0.43 0.494 0.645
    Amortization 0.665 0.666 0.665 0.666 0.665
    Non-Cash Items 13.853 14.614 10.191 10.766 12.226
    Changes in Working Capital -3.716 -6.197 3.2 0.86 0.113
    Cash From Investing Activities -0.401 7.563 10.044 -10.101 26.117
    Capital Expenditures -0.401 -0.437 -0.441 -0.608 -0.276
    Other Investing Cash Flow Items, Total 0 8 10.485 -9.493 26.393
    Cash From Financing Activities 79.939 62.685 30.885 0.082 45.496
    Financing Cash Flow Items 0 -0.232 -0.613 -0.115
    Issuance (Retirement) of Stock, Net 15.376 62.51 30.885 0.695 45.611
    Net Change in Cash 32.525 16.151 5.564 -44.204 47.717
    Deferred Taxes 0
    Issuance (Retirement) of Debt, Net 64.563 0.407
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -9.801 -58.505 -49.308 -31.269 -17.273
    Cash From Operating Activities -6.57 -47.013 -39.048 -28.416 -15.594
    Cash From Operating Activities 0.135 0.69 0.52 0.347 0.16
    Amortization 0.167 0.665 0.499 0.333 0.166
    Non-Cash Items 0.896 13.853 11.814 3.72 2.007
    Changes in Working Capital 2.033 -3.716 -2.573 -1.547 -0.654
    Cash From Investing Activities -0.039 -0.401 -0.36 -0.298 -0.279
    Capital Expenditures -0.039 -0.401 -0.36 -0.298 -0.279
    Other Investing Cash Flow Items, Total 0 0 0 0
    Cash From Financing Activities -0.432 79.939 79.956 14.898 -0.065
    Issuance (Retirement) of Stock, Net 0.485 15.376 15.393 15.335 0.372
    Issuance (Retirement) of Debt, Net -0.917 64.563 64.563 -0.437 -0.437
    Net Change in Cash -7.041 32.525 40.548 -13.816 -15.938
    Financing Cash Flow Items 0 0 0
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Duggan (Robert William) Individual Investor 66.7438 36644335 1667 2023-08-25 MED
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.5367 843685 621920 2023-06-30 LOW
    BofA Global Research (US) Research Firm 1.4253 782507 9773 2023-06-30 LOW
    Zanganeh (Mahkam) Individual Investor 1.2329 676910 86668 2023-06-09 MED
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5619 308513 166023 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.5284 290080 -278555 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.5184 284635 216534 2023-06-30 LOW
    Griffin Asset Management, Inc. Investment Advisor/Hedge Fund 0.5004 274760 80410 2023-09-30 LOW
    Uecker (Darrin R) Individual Investor 0.2713 148941 7365 2023-06-12
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.2704 148484 91326 2023-06-30 LOW
    Levinson (Mitchell E.) Individual Investor 0.1345 73860 10935 2023-05-25 LOW
    Westside Investment Management, Inc Investment Advisor 0.1277 70135 -40966 2023-06-30 LOW
    Spotlight Asset Group, Inc. Investment Advisor 0.121 66425 0 2023-06-30 LOW
    Osaic Holdings, Inc. Investment Advisor 0.1074 58982 2672 2023-06-30 LOW
    Nuveen LLC Pension Fund 0.0981 53851 26553 2023-06-30 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.0796 43695 43695 2023-06-30 LOW
    BlackRock Investment Management, LLC Investment Advisor/Hedge Fund 0.0779 42760 40128 2023-06-30 LOW
    BNY Mellon Asset Management Investment Advisor 0.0775 42573 690 2023-09-30 LOW
    Susquehanna International Group, LLP Investment Advisor 0.0757 41536 41536 2023-06-30 MED
    Millennium Management LLC Hedge Fund 0.0654 35881 1555 2023-06-30 HIGH

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Pulse Biosciences, Inc. Company profile

    About Pulse Biosciences Inc

    Pulse Biosciences, Inc. is a novel bioelectric medicine company. The Company's Nano-Pulse Stimulation (NPS) technology platform is designed to send energy pulses to cells in order to alter the function of the internal cellular organelles, including the mitochondria and endoplasmic reticulum, without disrupting extracellular tissue. Its commercial product CellFX System is is designed to function on the basis of a non-thermal mechanism of action in a biophysical disruption brought about by the tunable speed and amplitude of NPS pulses interacting with the physical structure of cells. The CellFX System includes a multi-use handpiece and an initial suite of five single use dermatology treatment tips.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, Pulse Biosciences Inc revenues increased from $0K to $574K. Net loss increased 34% to $48.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Medical therapy segment loss increase of 11% to $14.3M, United States segment loss increase of 11% to $14.3M.

    Industry: Advanced Medical Equipment & Technology (NEC)

    3957 Point Eden Way
    HAYWARD
    CALIFORNIA 94545-3720
    US

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    US100

    16,001.20 Price
    +0.470% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Oil - Crude

    74.50 Price
    -1.560% 1D Chg, %
    Long position overnight fee -0.0136%
    Short position overnight fee -0.0083%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    Gold

    2,072.25 Price
    +1.760% 1D Chg, %
    Long position overnight fee -0.0193%
    Short position overnight fee 0.0111%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    BTC/USD

    39,631.50 Price
    +0.010% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading